DP
Congress trade
Sen. David Perdue (R-GA) sold $15K-$50K of Pfizer Inc. (PFE) stock
David Perdue, U.S. Senator (R-GA), disclosed a sale of Pfizer Inc. (PFE) stock worth $15K-$50K in a STOCK Act filing on Nov 8, 2018.
The trade happened on Oct 31, 2018, 8 days before it was made public.
PFE has moved -32.0% since the trade date, from $40.85 to $27.80 (Oct 2, 2026 close).
- Traded
- Oct 31, 2018
- Disclosed
- Nov 8, 2018
- Filing delay
- 8 days
- Price since
- -32.0%
- Source
- STOCK Act disclosure
Other trades in this disclosure (53)
- BuyBAC$15K-$50KNov 8, 2018
- BuyBAC$15K-$50KNov 8, 2018
- BuyGM$15K-$50KNov 8, 2018
- BuyGPK$15K-$50KNov 8, 2018
- SellIP$15K-$50KNov 8, 2018
- SellMRK$15K-$50KNov 8, 2018
- SellPFE$15K-$50KNov 8, 2018
- SellWMB$15K-$50KNov 8, 2018
- SellAAPL$1K-$15KNov 8, 2018
- SellAAPL$1K-$15KNov 8, 2018
- BuyAXTA$1K-$15KNov 8, 2018
- BuyBAC$1K-$15KNov 8, 2018
- BuyCAT$1K-$15KNov 8, 2018
- SellCBS$1K-$15KNov 8, 2018
- BuyCZR$1K-$15KNov 8, 2018
- SellDISCA$1K-$15KNov 8, 2018
- SellDISCA$1K-$15KNov 8, 2018
- SellDISCA$1K-$15KNov 8, 2018
- SellDISCA$1K-$15KNov 8, 2018
- SellDISCA$1K-$15KNov 8, 2018
More PFE insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.